Search - tctmd.com

Displaying 261 - 280 of 2424

Sort: Relevancy | Date

Presentation TCT 2024

TCT 771: Sex Disparities in Patients With Suspected Non-ST Elevation Myocardial Infarction Undergoing Coronary Angiography: Insights From SCAAR and the Western Denmark Heart Registry

Presenter: Mikael Zhou

October 27, 2024

Presentation TCT 2024

TCT 1291: When a Heart Attack Succeeds

Presenter: Tibor Poruban

October 27, 2024

Presentation ESC 2024

INFINITY-SWEDEHEART: Percutaneous coronary intervention with a Bioadaptor compared to a contemporary Drug-eluting Stent (DES) in a large broad clinical population

Presenter: David Erlinge

September 02, 2024

Presentation ESC 2024

RAPIDxAI: Re-engineering the clinical approach to suspected cardiac chest pain assessment in the emergency department using artificial intelligence

Presenter: Derek Chew

September 02, 2024

Presentation ESC 2024

The EARTH-STEMI IPD meta-analysis

Presenter: Gianluca Campo

September 01, 2024

Presentation Interventional Complications 2024

Cardiogenic Shock Algorithm: Which Device Do I Go for First and Why?

Presenter: Sunu Thomas

August 02, 2024

Presentation EuroPCR 2024

First report of an IDE pivotal study of a dedicated splitting device during TAVR

Presenter: Danny Dvir

May 15, 2024

Presentation EuroPCR 2024

QFR for the revascularization of non-culprit lesions of older patients with myocardial infarction

Presenter: Andrea Erriquez

May 14, 2024

Presentation EuroPCR 2024

Prognostic value of MRR in STEMI: a pooled analysis of individual patient data

Presenter: Mohamed El Farissi

May 14, 2024

Presentation Fellows 2024

State-of-the-Art in NSTE-ACS: Management Strategies

Presenter: Binita Shah

April 12, 2024

Presentation Fellows 2024

Reperfusion Therapies in Myocardial Infarction: How Far We’ve Come

Presenter: David J. Cohen

April 12, 2024

$Coronary Sinus Reducer for the treatment of refractory angina: a randomised, placebo-controlled trial (ORBITA-COSMIC)$

Presentation ACC 2024

Coronary Sinus Reducer for the treatment of refractory angina: a randomised, placebo-controlled trial (ORBITA-COSMIC)

Presenter: Rasha K. Al-Lamee

April 08, 2024

Presentation ACC 2024

Percutaneous Transvalvular Micro axial Flow Pump in Infarct Related Cardiogenic Shock

Presenter: Jacob Eifer Møller

April 07, 2024

Presentation ACC 2024

Principal Results From the Double-blind, Placebo-controlled ULTIMATE-DAPT Trial

Presenter: Gregg W Stone

April 07, 2024

Presentation ACC 2024

The Effect of Edetate Disodium-based Chelation on Cardiovascular Events in Patients with a Prior Myocardial Infarction and Diabetes – Results of the TACT2 Randomized Trial

Presenter: Gervasio A. Lamas

April 07, 2024

Presentation ACC 2024

Empagliflozin after Acute Myocardial Infarction: The EMPACT-MI trial

Presenter: Javed Butler

April 06, 2024

Presentation THT 2024

Shock-Phenotype Matching Using Real-World Evidence: A New Paradigm for Prospective Enrollment in Clinical Trials of Acute MCS Devices in Cardiogenic Shock

Presenter: James W. Schurr

March 06, 2024

Presentation THT 2024

A Novel Study Design, Termed Molecular Triangulation, That Leverages Biologic Similarities Across Seemingly Different Shock Phenotypes In Order to Identify Novel Druggable Targets and Pathophysiologic Mechanisms.

Presenter: Thomas Hanff

March 06, 2024

Presentation THT 2024

DPP3-Based Biotherapy in Cardiogenic Shock

Presenter: Mahir Karakas

March 06, 2024

Presentation THT 2024

Ivabridine in Cardiogenic Shock

Presenter: Maya Guglin

March 06, 2024

Advertisement

TCT 771: Sex Disparities in Patients With Suspected Non-ST Elevation Myocardial Infarction Undergoing Coronary Angiography: Insights From SCAAR and the Western Denmark Heart Registry

TCT 1291: When a Heart Attack Succeeds

INFINITY-SWEDEHEART: Percutaneous coronary intervention with a Bioadaptor compared to a contemporary Drug-eluting Stent (DES) in a large broad clinical population

RAPIDxAI: Re-engineering the clinical approach to suspected cardiac chest pain assessment in the emergency department using artificial intelligence

The EARTH-STEMI IPD meta-analysis

Cardiogenic Shock Algorithm: Which Device Do I Go for First and Why?

First report of an IDE pivotal study of a dedicated splitting device during TAVR

QFR for the revascularization of non-culprit lesions of older patients with myocardial infarction

Prognostic value of MRR in STEMI: a pooled analysis of individual patient data

State-of-the-Art in NSTE-ACS: Management Strategies

Reperfusion Therapies in Myocardial Infarction: How Far We’ve Come

Coronary Sinus Reducer for the treatment of refractory angina: a randomised, placebo-controlled trial (ORBITA-COSMIC)

Percutaneous Transvalvular Micro axial Flow Pump in Infarct Related Cardiogenic Shock

Principal Results From the Double-blind, Placebo-controlled ULTIMATE-DAPT Trial

The Effect of Edetate Disodium-based Chelation on Cardiovascular Events in Patients with a Prior Myocardial Infarction and Diabetes – Results of the TACT2 Randomized Trial

Empagliflozin after Acute Myocardial Infarction: The EMPACT-MI trial

Shock-Phenotype Matching Using Real-World Evidence: A New Paradigm for Prospective Enrollment in Clinical Trials of Acute MCS Devices in Cardiogenic Shock

A Novel Study Design, Termed Molecular Triangulation, That Leverages Biologic Similarities Across Seemingly Different Shock Phenotypes In Order to Identify Novel Druggable Targets and Pathophysiologic Mechanisms.

DPP3-Based Biotherapy in Cardiogenic Shock

Ivabridine in Cardiogenic Shock

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content